Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Qiaoqiao Qian"'
Autor:
Yingying Xin, Liuliu Gao, Yali Tuo, Gang Nie, Yan Mei, Chen Chen, Jun Wang, Sichan Li, Dan Sun, Qiaoqiao Qian, Yongli Fu, Yang Wang, Zhisheng Liu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: This study aims to develop a combined population pharmacokinetic (PPK) model for aripiprazole (ARI) and its main active metabolite dehydroaripiprazole (DARI) in pediatric patients with tic disorders (TD), to investigate the inter-individua
Externí odkaz:
https://doaj.org/article/51602839ef7e439a87ab06ed98167961
Publikováno v:
Frontiers in Genetics, Vol 12 (2022)
Background: Gene variants of ADP-ribosylserine hydrosylase, also known as ADP-ribosylhydrolase-like 2 (ADPRS or ADPRLH2; OMIM: 610624), can cause stress-induced childhood-onset neurodegeneration with variable ataxia and seizures (CONDSIAS, OMIM: 6181
Externí odkaz:
https://doaj.org/article/f986f152383f493f848358deb4218fbb
Publikováno v:
Stem Cell Research, Vol 57, Iss , Pp 102589- (2021)
Brown-Vialetto-Van Laere syndrome-2 is a rare neurological disorder characterized by sensory neuronopathy and pontobulbar palsy, caused by variations in SLC52A2 and SLC52A3 genes, encoding the riboflavin transporters. By reprogramming with SOX2, KLF4
Externí odkaz:
https://doaj.org/article/2e627ff2788545d9b1b98e4316382106
Autor:
Yue Niu, Qiaoqiao Qian, Juan Li, Pan Gong, Xianru Jiao, Xiao Mao, Bo Xiao, Lili Long, Zhixian Yang
Publikováno v:
Clinical Genetics. 101:459-465
AGO1, as one of the rare genes in neurodevelopmental disorders, is involved in the microRNA-induced silencing complex. Here, we describe the clinical and genetic features of 18 individuals with de novo AGO1 variants: four new and 14 previously report
Autor:
Yingying Xin, Liuliu Gao, Yali Tuo, Gang Nie, Yan Mei, Chen Chen, Jun Wang, Sichan Li, Dan Sun, Qiaoqiao Qian, Yongli Fu, Yang Wang, Zhisheng Liu
Publikováno v:
Frontiers in Pharmacology; 12/1/2022, Vol. 13, p01-19, 19p
Publikováno v:
Stem Cell Research, Vol 57, Iss, Pp 102589-(2021)
Brown-Vialetto-Van Laere syndrome-2 is a rare neurological disorder characterized by sensory neuronopathy and pontobulbar palsy, caused by variations in SLC52A2 and SLC52A3 genes, encoding the riboflavin transporters. By reprogramming with SOX2, KLF4